Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men

    Anja Blumeyer, Antonella Tosti, Andrew G. Messenger, Pascal Reygagne, Véronique Del Marmol, Ph.I. Spuls, Myrto Trakatelli, Andreas Finner, Franklin Kiesewetter, Ralph M. Trüeb, Berthold Rzany, Ulrike Blume-Peytavi
    Image of study
    TLDR Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.
    This document is an evidence-based guideline for treating androgenetic alopecia (AGA) in men and women. It recommends using minoxidil as a primary treatment option, with 2% or 5% topical solutions being effective. Finasteride and dutasteride are recommended for men, while dutasteride is recommended for women. Combination therapies have shown promise, and hair transplantation is a viable option. The guideline also discusses various other treatments, but notes the lack of evidence for some. Overall, the guideline provides an overview of available treatments and studies on their efficacy for treating AGA in men and women.
    View this study on onlinelibrary.wiley.com →

    Cited in this study

    Related